IL-6/JAK/STAT3 signaling is able to drive the proliferation, survival, invasiveness, and metastasis of tumor cells, leading to a poor clinical prognosis in many types of cancers (Johnson et al., 2018). This evidence concerns the gene IL6 and neoplasm.